In this episode of REBEL Cast, we dive into part one of our Diabetic Ketoacidosis (DKA) series with a twist—subcutaneous insulin instead of the traditional IV drip. We explore the SQuID Protocol (Subcutaneous Insulin in DKA), which could potentially shift how we manage mild to moderate DKA—from the ICU to the general floor.
The post REBEL Core Cast – DKA: Beyond the Basics Part 1 – The SQuID Protocol appeared first on REBEL EM – Emergency Medicine Blog.
Diabetic Ketoacidosis, or DKA, is a severe complication of diabetes. The management of DKA is addressed through a systematic approach that includes fluid resuscitation, insulin administration, and dextrose as needed.
Initial treatment focuses on aggressive fluid replacement, typically with normal saline. A common approach involves an initial rapid bolus of fluid, followed by continuous infusion. This helps restore circulating volume, improve kidney function, and reduce blood glucose levels through dilution and increased urine output. The amount and rate of fluid are adjusted based on the patient’s hydration status and electrolyte levels.
Insulin is critical for stopping the production of ketones and lowering blood glucose. It is usually given as an initial intravenous bolus, followed by a continuous intravenous infusion. The insulin infusion rate is carefully adjusted to gradually lower blood glucose levels and resolve the metabolic acidosis. The target rate for glucose reduction is generally 50 to 75 milligrams per deciliter per hour.
Once blood glucose levels decrease to a certain point, typically around 200 to 250 milligrams per deciliter, dextrose is added to the intravenous fluids. This addition prevents hypoglycemia while allowing the continuous insulin infusion to continue at a rate sufficient to resolve the underlying acidosis. Often, 5 percent dextrose is used.
Beyond these primary components, other medical considerations are crucial. Potassium levels must be closely monitored and replaced as needed, because insulin shifts potassium into cells, which can lead to dangerously low levels. Bicarbonate administration is generally not recommended for most DKA cases, but it might be considered for severe acidosis, especially if the pH is below 6.9 or 7.0, due to potential risks. Phosphate replacement is usually not required unless levels are extremely low or specific symptoms develop.
Throughout the treatment, continuous monitoring of blood glucose, electrolytes, blood gas, and fluid balance is essential to guide therapy and prevent complications. The overall aim is to systematically reverse the metabolic disturbances of DKA.
https://rebelem.com/rebel-core-cast-dka-beyond-the-basics-part-1-the-squid-protocol/?utm_source=rss&utm_medium=rss&utm_campaign=rebel-core-cast-dka-beyond-the-basics-part-1-the-squid-protocol
